Medigene AG: Medigene presents at five upcoming conferences
(firmenpresse) - Medigene AG: Medigene presents at five upcoming conferences
Business news for the stock market
Planegg (29.05.2018) - Medigene AG (FSE: MDG1, Prime Standard, TecDAX) today announced its participation at the following upcoming conferences:
BIO International Convention
Date: 4 - 7 June 2018
Location: Boston, USA
Jefferies Global Healthcare Conference
Date: 5 - 8 June 2018
Locations: New York, USA
Prof. Dolores Schendel, CEO and CSO of Medigene AG, is invited to hold a company presentation on 7 June.
Biomarkers and Immuno-Oncology World Congress
Date: 11 - 13 June 2018
Location: Boston, USA
3rd Annual Oncology Day by Bryan Garnier & Co.
Date: 13 June 2018
Location: Paris, France
Prof. Dolores Schendel, CEO and CSO of Medigene AG, is invited to hold a company presentation.
23rd Congress of the European Hematology Association (EHA)
Date: 14 - 15 June 2018
Location: Stockholm, Sweden
Medigene AG (FSE: MDG1, ISIN DE000A1X3W00, Prime Standard, TecDAX) is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. The company is developing highly innovative immunotherapies to target various forms and stages of cancer. Medigene concentrates on the development of personalized T cell-based therapies, with associated projects currently in pre-clinical and clinical development.
For more information, please visit http://www.medigene.com
This press release contains forward-looking statements representing the opinion of Medigene as of the date of this release. The actual results achieved by Medigene may differ significantly from the forward-looking statements made herein. Medigene is not bound to update any of these forward-looking statements. Medigene® is a registered trademark of Medigene AG. This trademark may be owned or licensed in select locations only.
Contact Medigene AG
Julia Hofmann, Dr. Robert Mayer
Tel.: +49 - 89 - 20 00 33 - 33 01,
email: investor(at)medigene.com
In case you no longer wish to receive any information about Medigene, please inform us by e-mail (investor(at)medigene.com). We will then delete your address from our distribution list.
(end)
emitter: Medigene AG
address: Lochhamer Straße 11, 82152 Planegg
country: Germany
contact person: Medigene PR/IR
phone: +49 89 2000 33 3301
e-mail: investor(at)medigene.com
website: www.medigene.de
ISIN(s): DE000A1X3W00 (share)
stock exchanges: regulated market in Frankfurt; free market in Stuttgart, free market in Munich, free market in Hamburg, free market in Dusseldorf, free market in Hannover; open market in Berlin, Tradegate
Leseranfragen:
Die Medigene AG ist ein börsennotiertes Biotechnologie-Unternehmen mit Hauptsitz in Martinsried bei München.
" alt="Altiplano Reports Filing of NI 43-101 Technical Report on the Copper-Gold Resource for the Farellon Project in Chile">
" alt="Goliath Arranges $1,450,000 of Additional Funding ">
Datum: 29.05.2018 - 11:24 Uhr
Sprache: Deutsch
News-ID 576209
Anzahl Zeichen: 2957
contact information:
Town:
Wien
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 194 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Medigene AG: Medigene presents at five upcoming conferences
"
steht unter der journalistisch-redaktionellen Verantwortung von
Medigene AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
